rs373911322
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4BP6_Very_StrongBP7BS1BS2
The NM_001042432.2(CLN3):c.240G>A(p.Thr80Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000468 in 1,614,102 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001042432.2 synonymous
Scores
Clinical Significance
Conservation
Publications
- inherited retinal dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- neuronal ceroid lipofuscinosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neuronal ceroid lipofuscinosis 3Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLN3 | NM_001042432.2 | c.240G>A | p.Thr80Thr | synonymous_variant | Exon 5 of 16 | ENST00000636147.2 | NP_001035897.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000270 AC: 41AN: 152132Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000962 AC: 242AN: 251490 AF XY: 0.00127 show subpopulations
GnomAD4 exome AF: 0.000490 AC: 716AN: 1461852Hom.: 7 Cov.: 30 AF XY: 0.000650 AC XY: 473AN XY: 727232 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000256 AC: 39AN: 152250Hom.: 1 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74454 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
- -
- -
- -
not specified Benign:2
- -
- -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Neuronal ceroid lipofuscinosis Benign:1
- -
CLN3-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Neuronal ceroid lipofuscinosis 3 Benign:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at